Logo
x

Search

Subscribe Now

eli lilly

Eli Lilly Reports P-II (ALPACA) Trial Data of Lepodisiran for Heart Diseases

Eli Lilly Reports P-II (ALPACA) Trial Data of Lepodisiran for Heart Diseases

  • March 31, 2025
Eli Lilly and Incyte Highlight P-III (BRAVE-AA-PEDS) Trial Data of Baricitinib for Alopecia Areata at AAD 2025

Eli Lilly and Incyte Highlight P-III (BRAVE-AA-PEDS) Trial Data of Baricitinib for Alopecia Areata at AAD 2025

  • March 11, 2025
Eli Lilly Acquires OLX75016 from OliX Pharmaceuticals for Metabolic-Associated Steatohepatitis

Eli Lilly Acquires OLX75016 from OliX Pharmaceuticals for Metabolic-Associated Steatohepatitis

  • February 11, 2025
Eli Lilly Reveals VIVID-2 Study Data of Omvoh to Treat Crohn's Disease

Eli Lilly Reveals VIVID-2 Study Data of Omvoh to Treat Crohn's Disease

  • February 10, 2025
Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

  • January 16, 2025
Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

  • January 14, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.